Drug intelligence / Profile preview

Vitargin

Development stage
Unknown
Lead developer
Pragati Biocare
Modality
Small Molecules
Administration
Oral
01

Overview

Vitargin is a metabolic and hepatoprotective combination product developed and marketed by the Ukrainian company Ecopharm. It is formulated with two primary active ingredients: L-arginine and betaine. L-arginine is a semi-essential amino acid that acts as a substrate for nitric oxide synthase, leading to the production of nitric oxide which promotes vasodilation and improves microcirculation. Additionally, L-arginine is a key component of the urea cycle, aiding in the detoxification of ammonia. Betaine (trimethylglycine) serves as a methyl donor in the conversion of homocysteine to methionine and acts as an osmolyte, protecting hepatocytes from osmotic stress and supporting lipid metabolism to prevent or reduce hepatic steatosis. Vitargin is typically used to support liver function in conditions such as hepatitis, fatty liver disease (steatosis), and during recovery from physical exhaustion or toxic insults.

Brand names
VitarginВІТАРГІН
Other names
Arginine + Betaine
02

Targets

BHMT (Betaine-homocysteine S-methyltransferase)NOS1 (nNOS)

Beyond the preview

Go deeper on Vitargin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitargin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call